NCT01264419View on ClinicalTrials.gov

Silk Road Medical First in Man Study - Neuroprotection During Carotid Stenting and Angioplasty

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

June 30, 2012

Study Completion Date

July 31, 2012

Conditions
Carotid Artery Diseases
Interventions
DEVICE

Silk Road Embolic Protection System

System that delivers a carotid artery stent, via transcervical access using reverse flow cerebral protection, as treatment for high-grade extracranial carotid artery disease

Trial Locations (1)

40472

Augusta-Krankenhaus, Düsseldorf

Sponsors

Lead Sponsor

Silk Road Medical
All Listed Sponsors
lead

Silk Road Medical

INDUSTRY